Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Striatal cholinergic interneurons (ChIs) provide acetylcholine tone to the striatum and govern motor functions. Nicotine withdrawal elicits physical symptoms that dysregulate motor behavior. Here, the role of striatal ChIs in physical nicotine withdrawal is investigated. Mice under RNAi-dependent genetic inhibition of striatal ChIs (ChI) by suppressing the sodium channel subunit Na1.1, lessening action potential generation and activity-dependent acetylcholine release is first generated. ChI markedly reduced the somatic signs of nicotine withdrawal without affecting other nicotine-dependent or striatum-associated behaviors. Multielectrode array (MEA) recording revealed that ChI reversed ex vivo nicotine-induced alterations in the number of neural population spikes in the dorsal striatum. Notably, the drug repurposing strategy revealed that a clinically-approved antimuscarinic drug, procyclidine, fully mimicked the therapeutic electrophysiological effects of ChI. Furthermore, both ChI and procyclidine prevented the nicotine withdrawal-induced reduction in striatal dopamine release in vivo. Lastly, therapeutic intervention with procyclidine dose-dependently diminished the physical signs of nicotine withdrawal. The data demonstrated that the striatal ChIs are a critical substrate of physical nicotine withdrawal and that muscarinic antagonism holds therapeutic potential against nicotine withdrawal.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653618 | PMC |
| http://dx.doi.org/10.1002/advs.202402274 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cytisine Use Vs Nicotine Replacement Therapy in Relapsed Smokers with Heart Disease: Feasibility Results from a Pilot Randomized Trial.
CJC Open
August 2025
University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Background: Cytisine use has proven efficacy for smoking cessation. We plan to investigate whether cytisine use is effective for relapse recovery and conducted a pilot randomized trial to assess the feasibility of a definitive trial.
Methods: A 2-group, single-site pilot randomized controlled trial was conducted.
Nicotine and neurocognition in HIV: Translational challenges and therapeutic potential.
Neurosci Biobehav Rev
August 2025
Department of Psychiatry, University of California, San Diego 9500 Gilman Drive, La Jolla, CA 92093, USA; Research Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. Electronic address:
Approximately half of people with HIV (PWH) experience neurocognitive impairment (NCI), despite antiretroviral therapies that have turned what was formerly a death sentence to a chronic illness. No targeted treatments exist for HIV-associated NCI, impacting long-term quality of life. Smoking rates in PWH are nearly double those of the general population, and with evidence for pro-cognitive effects of nicotine, this may reflect self-medication.
View Article and Find Full Text PDFEfficacy and Safety of NFL-101 as a Smoking Cessation Therapy: A Randomized Phase II Clinical Trial CESTO2.
Nicotine Tob Res
August 2025
NFL Biosciences, Castelnau-Le-Lez, France.
Introduction: Tobacco addiction remains a major public health challenge. Existing smoking cessation treatments require prolonged daily use with potentially poor adherence and reduced efficacy.
Methods: The phase II study was a multicenter, randomized, double-blind, placebo-controlled trial with a one-year follow-up to assess the efficacy, safety, and immunogenicity of NFL-101 as a potential aid for smoking cessation.
Oral adverse event reporting in smoking cessation trials using non-combustible nicotine products: A quality assessment.
J Dent
August 2025
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Center for the Acceleration of Harm Reduction, University of Catania, Catania, Italy.
Objectives: To assess the completeness and quality of reporting of oral adverse events (OAEs) in randomized controlled trials (RCTs) that evaluated non-combustible nicotine products (NCNPs) and whether reporting practices have improved over time.
Data Sources And Study Selection: This secondary data analysis was based on 36 RCTs included in a previous systematic review. Trials involved adult smokers and included nicotine replacement therapy, electronic cigarettes, heated tobacco, and smokeless tobacco.
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity.
Headache
August 2025
Department of Neurology, Beni-Suef University, Beni-Suef, Egypt.
Background: Nicotine withdrawal has not been studied before as a contributing factor for headache exacerbations during Ramadan. Therefore, we aimed to explore the impact of smoking status and nicotine dependence on the frequency and severity of primary headache disorders during fasting.
Methods: This prospective cohort study with pre-post comparisons was conducted on male smokers and nonsmokers with primary headache disorders.